JP2003504338A5 - - Google Patents

Download PDF

Info

Publication number
JP2003504338A5
JP2003504338A5 JP2001508987A JP2001508987A JP2003504338A5 JP 2003504338 A5 JP2003504338 A5 JP 2003504338A5 JP 2001508987 A JP2001508987 A JP 2001508987A JP 2001508987 A JP2001508987 A JP 2001508987A JP 2003504338 A5 JP2003504338 A5 JP 2003504338A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
dosage form
omeprazole
proton pump
pump inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001508987A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003504338A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/018896 external-priority patent/WO2001003707A1/en
Publication of JP2003504338A publication Critical patent/JP2003504338A/ja
Publication of JP2003504338A5 publication Critical patent/JP2003504338A5/ja
Pending legal-status Critical Current

Links

JP2001508987A 1999-07-12 2000-07-12 胸やけの処置法 Pending JP2003504338A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14340799P 1999-07-12 1999-07-12
US60/143,407 1999-07-12
PCT/US2000/018896 WO2001003707A1 (en) 1999-07-12 2000-07-12 Heartburn treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012095818A Division JP2012153712A (ja) 1999-07-12 2012-04-19 胸やけの処置法

Publications (2)

Publication Number Publication Date
JP2003504338A JP2003504338A (ja) 2003-02-04
JP2003504338A5 true JP2003504338A5 (enExample) 2007-07-26

Family

ID=22503933

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001508987A Pending JP2003504338A (ja) 1999-07-12 2000-07-12 胸やけの処置法
JP2012095818A Pending JP2012153712A (ja) 1999-07-12 2012-04-19 胸やけの処置法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012095818A Pending JP2012153712A (ja) 1999-07-12 2012-04-19 胸やけの処置法

Country Status (5)

Country Link
EP (1) EP1210091A4 (enExample)
JP (2) JP2003504338A (enExample)
AU (1) AU6087100A (enExample)
CA (1) CA2378018A1 (enExample)
WO (1) WO2001003707A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
DE60138044D1 (de) * 2000-12-28 2009-04-30 Tap Pharmaceutical Prod Inc Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination
AU2003900096A0 (en) * 2003-01-10 2003-02-20 Nature Vet Orally deliverable pharmaceutical composition protein pump inhibitors
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN109906079B (zh) 2016-06-16 2022-09-30 库蒂斯制药公司 用于质子泵抑制剂混悬剂的组合物和方法
WO2018049184A1 (en) 2016-09-09 2018-03-15 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
JP3833314B2 (ja) * 1995-09-08 2006-10-11 武田薬品工業株式会社 発泡性組成物およびその製造方法
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
US5840737A (en) * 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
WO1999053918A1 (en) * 1998-04-20 1999-10-28 Eisai Co., Ltd. Stabilized compositions containing benzimidazole-type compounds

Similar Documents

Publication Publication Date Title
US9278080B2 (en) Compositions and methods for inhibiting gastric acid secretion
JP6037840B2 (ja) 口腔内崩壊錠
UA69396C2 (uk) ПЕРОРАЛЬНА ДОЗОВАНА ФАРМАЦЕВТИЧНА ФОРМА З ДИСКРЕТНИМ ВИВІЛЬНЕННЯМ ІНГІБІТОРА Н<sup>+</sup>,К<sup>+</sup>,-АТФ-АЗИ (ВАРІАНТИ) ТА СПОСІБ ЇЇ ОДЕРЖАННЯ (ВАРІАНТИ) І СПОСІБ ЛІКУВАННЯ (ВАРІАНТИ)
HRP20000380A2 (en) Oral pharmaceutical extended release dosage form
JP2007506775A5 (enExample)
DE60032749D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
JP2003504338A5 (enExample)
KR20060015641A (ko) 트립탄 및 ｎｓａｉｄ를 포함하는 조성물
US9370481B2 (en) Compositions and methods for inhibiting gastric acid secretion
CA2648538A1 (en) Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles
CA2658804A1 (en) Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
JP2013006843A (ja) 胃酸分泌
HK1120421B (en) Compositions and their preparation methods for inhibiting gastric acid secretion